In Vitro Susceptibility to Miltefosine of <i>Leishmania infantum</i> (syn. <i>L.</i> <i>chagasi</i>) Isolates from Different Geographical Areas in Brazil

In Vitro Susceptibility to Miltefosine of <i>Leishmania infantum</i> (syn. <i>L.</i> <i>chagasi</i>) Isolates from Different Geographical Areas in Brazil

Treatment of visceral leishmaniasis in Brazil still relies on meglumine antimoniate, with less than ideal efficacy and safety, making new therapeutic tools an urgent need. The oral drug miltefosine was assayed in a phase II clinical trial in Brazil with cure rates lower than previously demonstrated...

Bibliografske podrobnosti
Main Authors:	Caroline Ricce Espada, Erica V. de Castro Levatti, Mariana Côrtes Boité, Dorcas Lamounier, Jorge Alvar, Elisa Cupolillo, Carlos Henrique Nery Costa, Joelle Rode, Silvia R. B. Uliana
Format:	Article
Jezik:	English
Izdano:	MDPI AG 2021-06-01
Serija:	Microorganisms
Teme:	clinical strains miltefosine susceptibility visceral leishmaniasis
Online dostop:	https://www.mdpi.com/2076-2607/9/6/1228

Podobne knjige/članki

Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with <i>Leishmania infantum</i>
od: Ana Isabel Olías-Molero, et al.
Izdano: (2023-02-01)

In-Depth Quantitative Proteomics Characterization of In Vitro Selected Miltefosine Resistance in <i>Leishmania infantum</i>
od: Leonardo Saboia-Vahia, et al.
Izdano: (2022-03-01)

Positive kidney profile of dogs with Leishmania sp. and treated with miltefosine
od: Danillo Brenno de Assis Torres, et al.
Izdano: (2024-03-01)

In Vitro and Ex Vivo Synergistic Effect of Pyrvinium Pamoate Combined with Miltefosine and Paromomycin against <i>Leishmania</i>
od: Estela Melcón-Fernández, et al.
Izdano: (2024-01-01)

In Vitro Antifungal Susceptibility Profile of Miltefosine against a Collection of Azole and Echinocandins Resistant <i>Fusarium</i> Strains
od: Mohsen Nosratabadi, et al.
Izdano: (2022-07-01)

Potential Inhibitory Effect of Miltefosine against Terbinafine-Resistant <i>Trichophyton indotineae</i>
od: Iman Haghani, et al.
Izdano: (2023-04-01)

Structure and Antiparasitic Activity Relationship of Alkylphosphocholine Analogues against <i>Leishmania donovani</i>
od: Humera Ahmed, et al.
Izdano: (2020-07-01)

Tolerability and Safety of Miltefosine for the Treatment of Cutaneous Leishmaniasis
od: Nadav Astman, et al.
Izdano: (2024-09-01)

Development and evaluation of miltefosine-loaded nanoemulsions on in vitro culture of Toxoplasma gondii
od: Gholam Valizadeh, et al.
Izdano: (2024-04-01)

Retrospective Long-Term Evaluation of Miltefosine-Allopurinol Treatment in Canine Leishmaniosis
od: Manuela Gizzarelli, et al.
Izdano: (2023-06-01)

Effectiveness of Miltefosine Nanoemulsion Concerning the Treatment of Acute and Chronic Toxoplasmosis: In Vivo Study
od: Gholam Reza Valizadeh, et al.
Izdano: (2024-08-01)

<i>Sporothrix</i> spp. Biofilms Impact in the Zoonotic Transmission Route: Feline Claws Associated Biofilms, Itraconazole Tolerance, and Potential Repurposing for Miltefosine
od: Giulia Maria Pires dos Santos, et al.
Izdano: (2022-02-01)

Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
od: Lu Lu, et al.
Izdano: (2020-12-01)

Infectiousness to sand flies of a cat naturally infected with Leishmania infantum at the moment of diagnosis and after three different courses of treatment
od: Mariana Dantas da Silva, et al.
Izdano: (2025-02-01)

Use of miltefosine in the treatment of cutaneous leishmaniasis in French Guiana
od: Charlene Oliveira, et al.
Izdano: (2024-07-01)

Thermoterapy effective and safer than miltefosine in the treatment of cutaneous leishmaniasis in Colombia
od: Liliana López, et al.
Izdano: (2013-06-01)

Antiparasitic properties of miltefosine-based nanoformulations against protozoan pathogen, Acanthamoeba castellanii
od: Noor Akbar, et al.
Izdano: (2022-01-01)

Characterization of <i>Leishmania</i> Parasites Isolated from Naturally Infected Mammals
od: Aroia Burguete-Mikeo, et al.
Izdano: (2023-06-01)

CRISPR-Cas9 high-throughput screening to study drug resistance in Leishmania infantum
od: Marine Queffeulou, et al.
Izdano: (2024-07-01)

Evaluation of In Vitro Cytotoxic and Apoptotic Effects of Miltefosine on the Toxoplasma gondii RH Strain
od: Shahram Khademvatan, et al.
Izdano: (2024-02-01)

Monitoring Cutaneous Leishmaniasis Lesions in Mice Undergoing Topical Miltefosine Treatment
od: Laura Fernanda Neira, et al.
Izdano: (2023-11-01)

Critically Appraised Topic on Canine Leishmaniosis: Does Treatment with Antimonials and Allopurinol Have the Same Clinical and Clinicopathological Efficacy as Treatment with Miltefosine and Allopurinol, after One Month of Treatment?
od: Marina García, et al.
Izdano: (2024-05-01)

Efeitos da suplementação do aminoácido L-Citrulina na infecção experimental por Leishmania infantum (Syn. L. chagasi)
od: Raniella Borges da Silva, et al.
Izdano: (2024-09-01)

Synergistic Effects of Artesunate in Combination with Amphotericin B and Miltefosine against <i>Leishmania infantum</i>: Potential for Dose Reduction and Enhanced Therapeutic Strategies
od: Nuchpicha Intakhan, et al.
Izdano: (2024-08-01)

Topical Sustained Delivery of Miltefosine Via Drug-Eluting Contact Lenses to Treat Acanthamoeba Keratitis
od: Lin Chen, et al.
Izdano: (2022-12-01)

Reproduction of Leishmania (Leishmania ) infantum chagasi in conditioned cell culture growth medium Isolamento e crescimento de Leishmania (Leishmania) infantum chagasi em meio de crescimento condicionado de cultura celular
od: Yeda L. Nogueira, et al.
Izdano: (2006-06-01)

Oral and Intragastric: New Routes of Infection by <i>Leishmania braziliensis</i> and <i>Leishmania infantum</i>?
od: Mayra M. Reimann, et al.
Izdano: (2022-06-01)

Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era
od: Sushmita Ghosh, et al.
Izdano: (2024-06-01)

Failure of Miltefosine Treatment in Two Dogs with Natural Leishmania infantum Infection
od: Daniela Proverbio, et al.
Izdano: (2014-01-01)

Clinical Improvement of Disseminated Acanthamoeba Infection in a Patient with Advanced HIV Using a Non-Miltefosine-Based Treatment Regimen in a Low-Resource Setting
od: Denasha L. Reddy, et al.
Izdano: (2022-02-01)

In Vitro Evaluation of the Combinatorial Effect of Naringenin and Miltefosine against <i>Leishmania amazonensis</i>
od: Vinícius Lopes Lessa, et al.
Izdano: (2024-08-01)

The zinc cluster transcription factor Znc1 regulates Rta3-dependent miltefosine resistance in Candida albicans
od: Bernardo Ramírez-Zavala, et al.
Izdano: (2024-07-01)

THE SERO-CONVERSION AND EVALUATION OF RENAL ALTERATIONS IN DOGS INFECTED BY Leishmania (Infantum) chagasi
od: Georgia Brenda Barros Alves, et al.
Izdano: (2013-04-01)

Thermoterapy effective and safer than miltefosine in the treatment of cutaneous leishmaniasis in Colombia Termoterapia efectiva y más segura que la miltefosina en el tratamiento de la leishmaniasis cutánea en Colombia
od: Liliana López, et al.
Izdano: (2013-06-01)

Characterization of Regulatory T Cells in Patients Infected by <i>Leishmania Infantum</i>
od: Rephany F. Peixoto, et al.
Izdano: (2022-12-01)

<i>Leishmania infantum</i> Infection of Primary Human Myeloid Cells
od: Morgane Picard, et al.
Izdano: (2022-06-01)

A Calcium- and GTP-Dependent Transglutaminase in <i>Leishmania infantum</i>
od: Shawgi Hago Almugadam, et al.
Izdano: (2023-03-01)

Leishmanicidal Activity of Guanidine Derivatives against <i>Leishmania infantum</i>
od: Fernanda Silva Almeida, et al.
Izdano: (2023-02-01)

New Compounds against <i>Leishmania infantum</i> from <i>Eremurus persicus</i>
od: Emanuela Martino, et al.
Izdano: (2019-08-01)

Ultrastructural Analysis of Leishmania infantum chagasi Promastigotes Forms Treated In Vitro with Usnic Acid
od: João S. B. da Luz, et al.
Izdano: (2015-01-01)